MicroStrategy
MSTR
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Coinbase
COIN
US Stock MarketDetailed Quotes
GILD Gilead Sciences
- 92.380
- +0.040+0.04%
Close Dec 11 16:00 ET
- 93.000
- +0.620+0.67%
Pre 08:40 ET
115.13BMarket Cap1026.44P/E (TTM)
94.650High91.940Low7.53MVolume92.400Open92.340Pre Close698.92MTurnover0.61%Turnover Ratio20.53P/E (Static)1.25BShares98.90052wk High6.23P/B114.90BFloat Cap60.75052wk Low3.06Dividend TTM1.24BShs Float98.900Historical High3.31%Div YieldTTM2.94%Amplitude0.405Historical Low92.874Avg Price1Lot Size
About Gilead Sciences Company
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Company Profile
SymbolGILD
Company NameGilead Sciences
Listing DateJan 22, 1992
Issue Price15.00
Founded1987
CEOMr. Daniel P. O'Day
MarketNASDAQ
Employees18000
Fiscal Year Ends12-31
Address333 Lakeside Drive
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-574-3000
Websitehttp://www.gilead.com
Company Executives
- Name
- Position
- Salary
- Daniel P. O'Day
- Chairman of the Board and Chief Executive Officer
- 22.61M
- Daniel O’Day
- Chairman of the Board and Chief Executive Officer
- --
- Johanna Mercier
- Chief Commercial Officer
- 8.59M
- Andrew D. Dickinson
- Chief Financial Officer
- 8.11M
- Dr. Merdad V. Parsey, M.D.,PhD
- Chief Medical Officer
- 8.39M
- Sandra Patterson
- Senior Vice President, Assistant Controller and Chief Accounting Officer
- --
- Deborah H. Telman
- Executive Vice President, Corporate Affairs, Corporate Secretary and General Counsel
- 5.27M
- Dr. Ted W. Love, M.D.
- Director
- --
- Kelly Anne Kramer
- Independent Director
- 434.92K
- Jeffrey A. Bluestone
- Independent Director
- 409.92K
- Anthony Welters
- Independent Director
- 444.92K
- Javier J. Rodriguez
- Independent Director
- 399.92K
- Harish Manwani
- Independent Director
- 414.92K
- Dr. Sandra J. Horning, M.D.
- Independent Director
- 429.92K
- Dr. Jacqueline K. Barton, PhD
- Independent Director
- 429.92K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
